Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > Reverse split and uplist to NASDAQ.
View:
Post by loveshackdave on May 28, 2015 4:02pm

Reverse split and uplist to NASDAQ.

Anyone on the ONCSD train today (I was :)? They reverse split a while back and are uplisting to NASDAQ tomorrow. I wonder what a similar action would do to TST stock price? I should think that it would help catch the interest of US investment firms.
Comment by DamnYankees on May 28, 2015 8:51pm
LSD, a reverse would shave 50% off the market cap, with no trouble whatsoever. So yes I think that option is on the plate once they shuffle out a22 cent US placement. They are fine in the US. check out the trend since the U.S. institutional awareness campaign kicked off. Why mess with a dead thing LSD?
Comment by txbioinv on May 28, 2015 9:43pm
dave, yes......they need to do a RS and just get it over with. After next offering, if there one, TST will be solidly over 200M share count. Lion Biotech did it with success; are RS more than often positive? No, but mgmt needs to seriously consider it and uplist on US exchange, probably NYSE(Nasdaq much tougher requirements), as a 10 for 1 will put us in the $2.75 USD range; TST has NO ...more  
Comment by txbioinv on May 28, 2015 9:59pm
dave, lastly..........with our share float so massive with no tute support, MM/brokers in Canada, with nominal positions can control this with like a ping pong with ease. If anyone else sees this, I urge you to start emailing the COO; and to you very large shareholders like douche granpa who I know reads this board, too faaaacken bad if a RS happens.
Comment by HighteawithIntrepid on May 28, 2015 10:30pm
FYI newbies We have already had one reverse split.
Comment by txbioinv on May 28, 2015 10:57pm
HT, I have been a shareholder in TST since Fall/2009. Could you please give me an approximate time frame when the first RS was done? I researched previous charts but with the name change all the old info not available. I will try the Stockhouse chart screens. It must have been sometime before they sold off their previous crown jewel/injectable business that I imagine was pissed away due to lack of ...more  
Comment by HighteawithIntrepid on May 28, 2015 11:18pm
not sure when, try yahoo. Or ask the corp.  you arrived  up to 10 years after they first traded so before you arrived. HT
Comment by princeofcut on Jul 17, 2015 1:24pm
bionut posted this public admission of supreme bagholderitist  I<< have been a shareholder in TST since Fall/2009.>>> man oh man what a bagholder you got rubed ...that is me laughing in your bagholder face...but wait it goes on...<>. more stunning rubisms. bionut regularly pumps this RS and US listing hilarity as the road to shareholder nirvana...way too funny..i now ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities